However, the NADPH-oxidase activity (which also uses NADPH as a cofactor) is increased (producing H2O2) during active vitiligo, therefore increasing ROS and promoting an active competition with EAS enzymes for NADPH molecules, a molecule already reduced in active vitiligo patients (Shajil and Begum, 2006). The gene discussed is FMO5; the disease is vitiligo.